Apo-2L
Term · Oncology and biomedicine · MLC-T-ONC-000686
A cell protein that can attach to certain molecules in some cancer cells and may kill the cells. Apo-2L is being studied in the treatment of cancer. Also called TNF-related apoptosis-inducing ligand, TRAIL, and tumor necrosis factor-related apoptosis-inducing ligand.
| Identifier | MLC-T-ONC-000686 |
|---|---|
| Field | Oncology and biomedicine |
| Expansions | TNF-related apoptosis-inducing ligand; tumor necrosis factor-related apoptosis-inducing ligand |
| Synonyms | TRAIL |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-000686",
"term": "Apo-2L",
"field": "Oncology and biomedicine",
"definition": "A cell protein that can attach to certain molecules in some cancer cells and may kill the cells. Apo-2L is being studied in the treatment of cancer. Also called TNF-related apoptosis-inducing ligand, TRAIL, and tumor necrosis factor-related apoptosis-inducing ligand.",
"expansions": [
"TNF-related apoptosis-inducing ligand",
"tumor necrosis factor-related apoptosis-inducing ligand"
],
"synonyms": [
"TRAIL"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/apo-2l/"
}
Record 2,379 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.